Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study).
- DOI
- 10.1007/s40744-026-00870-1
- Published
- 2026 Aug
- Container
- Rheumatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-026-00870-1,
title = {Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study).},
author = {Tanaka Y and Kodama Y and Nakayamada S and Masamune A and Sato H and Takahashi A and Shibata J and Takeshima Y and Kawano M},
year = {2026},
journal = {Rheumatology and therapy},
doi = {10.1007/s40744-026-00870-1},
url = {https://doi.org/10.1007/s40744-026-00870-1}
}RIS
TY - JOUR TI - Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study). AU - Tanaka Y AU - Kodama Y AU - Nakayamada S AU - Masamune A AU - Sato H AU - Takahashi A AU - Shibata J AU - Takeshima Y AU - Kawano M PY - 2026 JO - Rheumatology and therapy DO - 10.1007/s40744-026-00870-1 UR - https://doi.org/10.1007/s40744-026-00870-1 ER -
APA
Y, T., Y, K., S, N., A, M., H, S., A, T., J, S., Y, T., & M, K. (2026). Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study).. Rheumatology and therapy. https://doi.org/10.1007/s40744-026-00870-1
Source records
- pubmed · retrieved 2026-09-27T12:22:20.374Z